Mayo Clinic
1 registered trial on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction NCT05371496 | Semaglutide | Phase 4 | Completed | Mayo Clinic | 81 | Jul 17, 2026 | Aug 14, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.